NHS launches trial of blood test designed to detect hard-to-diagnose cancers
The STRIDE-RCT study is being rolled out across 200 GP practices to determine if blood tests can identify cancers like pancreatic and ovarian at an earlier, more treatable stage. By analysing DNA fragments in patients with vague symptoms, the trial aims to help doctors prioritise urgent investigations while providing quicker reassurance to those who do not need them.
Source: Bristol Post
National
Read the full story